SYK · Stryker Corporation
$306.13
-0.33% last session
End-of-day data · close of 2026-10-26
Market cap
$117B
Enterprise value
$129B
Trailing P/E
31.7
Forward P/E
18.4
Dividend yield
1.0%
Beta
0.78
Avg volume
3M
Employees
56K
Daily Change %
-0.33%
5 Days Change
-0.31%
10 Days Change
3.89%
30 Days Change
12.75%
60 Days Change
-7.13%
Month to Day Change
12.15%
Year to Day Change
-12.15%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — SYK
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-12
Latest call per bank · past 12 months
Barclays
Overweight$375
+22.5% vs priceCitigroup
Buy$360
+17.6% vs priceWells Fargo
Overweight$348
+13.7% vs priceRBC Capital
Outperform$420
+37.2% vs priceJP Morgan
Overweight$350
+14.3% vs priceGoldman Sachs
Neutral$357
+16.6% vs priceUBS
Neutral$380
+24.1% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | BTIG | Maintains | Buy | $358 → $316 |
| 2026-10-07 | Truist Securities | Maintains | Hold | $340 → $310 |
| 2026-10-07 | Barclays | Initiates | Overweight | $0.00 → $375 |
| 2026-09-30 | Stifel | Maintains | Buy | $360 → $330 |
| 2026-09-22 | TD Cowen | Maintains | Hold | $355 → $298 |
| 2026-09-18 | Canaccord Genuity | Maintains | Buy | $400 → $385 |
| 2026-09-10 | Citigroup | Maintains | Buy | $399 → $360 |
| 2026-09-09 | Wells Fargo | Maintains | Overweight | $418 → $348 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-26
- neutral: RSI (14): RSI is 63 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 3.9% above the 50-day MA ($294.56).
- bearish: Price vs 200-day MA: Trading 5.3% below the 200-day MA ($323.27).
- bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- bullish: MACD (12,26,9): MACD histogram is positive (+3.72) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($268.90) and high ($384.17).
SYK Price Chart
Loading chart for SYK…
Fundamentals
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
More in Medical Devices
ABT
Abbott Laboratories
$181B -14.2% YTD
MDT
Medtronic plc.
$121B 1.2% YTD
BSX
Boston Scientific Corporation
$66B -52.2% YTD
EW
Edwards Lifesciences Corporatio
$52B 6.2% YTD
GEHC
GE HealthCare Technologies Inc.
$33B -12.1% YTD
DXCM
DexCom, Inc.
$30B 18.4% YTD
PHG
Koninklijke Philips N.V. NY Reg
$26B 1.9% YTD
STE
STERIS plc (Ireland)
$22B -8.5% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.